| Size & multiples | |||
| Market Cap | $370.7M | Enterprise Value | $228.8M |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 45.76× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | 28.24× | EV/FCF | — |
| FCF Yield | −25.05% | Buyback Yield | — |
| Owner Earnings (TTM) | -$98.7M | Owner Earnings Yield | −26.63% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.37 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 5.86% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | −160.20% | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
Flows TTM (last 4 quarters) · EPS TTM — · revenue TTM $8.1M · FCF TTM -$92.8M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -23.1% | -7.8% | -34.7%–1.4% | 33 ↓weak |
| Net Margin | -1218.4% | -21.2% | -325.3%–7.2% | 15 ↓weak |
| Operating Margin | -1336.7% | -34.5% | -552.0%–8.0% | 18 ↓weak |
| ROE | -76.0% | -36.8% | -92.5%–4.5% | 30 ↓weak |
